Tennant Co. v. Oxygenator Water Technologies, Inc.

CourtCourt of Appeals for the Federal Circuit
DecidedJuly 23, 2024
Docket22-2304
StatusUnpublished

This text of Tennant Co. v. Oxygenator Water Technologies, Inc. (Tennant Co. v. Oxygenator Water Technologies, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Tennant Co. v. Oxygenator Water Technologies, Inc., (Fed. Cir. 2024).

Opinion

Case: 22-2304 Document: 48 Page: 1 Filed: 07/23/2024

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

TENNANT CO., Appellant

v.

OXYGENATOR WATER TECHNOLOGIES, INC., Appellee ______________________

2022-2304 ______________________

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2021- 00625. ______________________

Decided: July 23, 2024 ______________________

OLIVER RICHARDS, Fish & Richardson P.C., San Diego, CA, argued for appellant. Also represented by NITIKA GUPTA FIORELLA, DOUGLAS E. MCCANN, JOSEPH B. WARDEN, Wilmington, DE.

J. DEREK VANDENBURGH, Carlson, Caspers, Vanden- burgh & Lindquist, P.A., Minneapolis, MN, argued for ap- pellee. Also represented by NATHAN D. LOUWAGIE, HANNAH MOSBY O'BRIEN, AARON W. PEDERSON. ______________________ Case: 22-2304 Document: 48 Page: 2 Filed: 07/23/2024

Before DYK, REYNA, and STOLL, Circuit Judges. DYK, Circuit Judge. Tennant Co. (“Tennant”) appeals from a decision of the Patent and Trial Appeal Board (“Board”) finding that claims 13, 14, and 17–27 of U.S. Patent No. RE45,415E (the “’415 patent”) were not unpatentable as anticipated or ob- vious. We conclude that substantial evidence supports the Board’s finding that the claim limitation requiring nano- bubbles was not shown to be inherent in the prior art by Tennant’s testing of the prior art or by establishing that the prior art used the same spacing of the electrodes as the ’415 patent. However, because the Board failed to address Tennant’s argument that the prior art practiced all the claimed parameters of the ’415 patent and thus inherently anticipated the claimed nanobubbles limitation, we reverse and remand. BACKGROUND Oxygenator Water Technologies, Inc. (“OWT”) is the owner of the ’415 patent. The patent is directed to a method for oxygenating water by “generat[ing] very small microbubbles and nanobubbles of oxygen in an aqueous medium, which bubbles are too small to break the surface tension of the medium, resulting in a medium supersatu- rated with oxygen.” ’415 patent, col. 2, l. 67–col. 3, l. 3. Claim 13 of the ’415 patent is the only independent claim at issue on appeal, and it provides: 13. A method for producing an oxygenated aqueous composition comprising: flowing water at a flow rate no greater than 12 gallons per minute through an electrol- ysis emitter comprising an electrical power source electrically connected to an anode electrode and a cathode electrode contained in a tubular housing, Case: 22-2304 Document: 48 Page: 3 Filed: 07/23/2024

TENNANT CO. v. OXYGENATOR WATER TECHNOLOGIES, INC. 3

causing electricity to flow from the power source to the electrodes, and, producing the composition comprising a suspension comprising oxygen microbub- bles and nanobubbles in the water, the mi- crobubbles and nanobubbles having a bubble diameter of less than 50 microns, wherein: the electrode is separated at a crit- ical distance from the cathode such that the critical distance is from 0.005 inches to 0.140 inches; the power source produces a volt- age no greater than about 28.3 volts and an amperage no greater than about 13 amps, the tubular housing has an inlet and an outlet and a tubular flow axis from the inlet to the outlet; the water flows in the inlet, out the outlet, is in fluid connection with the electrodes, and the water flow- ing into the inlet has a conductivity produced by the presence of dis- solved solids such that the water supports plant or animal life. ’415 patent, col. 11, ll. 20–45. Tennant petitioned for inter partes review of claims 13, 14, and 17–27 of the ’415 patent alleging anticipation over two prior art references, U.S. Patent No. 3,891,535 (“Wikey”) and U.S. Patent No. 4,917,782 (“Davies”), and ob- viousness over either Wikey in combination with other prior art references or Davies in combination with other prior art references. The Board first found that Case: 22-2304 Document: 48 Page: 4 Filed: 07/23/2024

“[Tennant’s] testing does not sufficiently demonstrate that Wikey inherently discloses nanobubbles.” J.A. 28. Second, the Board found that “[Tennant’s] reliance on milkiness and supersaturation to demonstrate the presence of nano- bubbles [wa]s also unsupported.” J.A. 28. Third, the Board found that “the ’415 patent itself does not necessarily equate a certain critical distance of electrodes with the for- mation of nanobubbles or microbubbles, to the exclusion of all other variables.” J.A. 26. For the dependent claims, the Board found that “[e]very dependent claim challenged . . . includes the microbubbles and nanobubbles limitation of claim 13, and, accordingly, [Tennant] does not make its case as to these dependent claims.” J.A. 31. In summary, the Board determined that Tennant “ha[d] not shown by a preponderance of the evidence that claims 13, 14, and 17– 27 of the ’415 patent are unpatentable” as anticipated or obvious. J.A. 2. Tennant appeals. We have jurisdiction pursuant to 28 U.S.C. § 1295(a)(4)(A). DISCUSSION We first consider the question of anticipation. “Antici- pation is a question of fact that we review for substantial evidence.” HTC Corp. v. Cellular Commc’ns Equip., LLC, 877 F.3d 1361, 1368 (Fed. Cir. 2017). Substantial evidence is “such relevant evidence as a reasonable mind might ac- cept as adequate to support a conclusion.” Consol. Edison Co. of New York v. NLRB, 305 U.S. 197, 229 (1938). “A claim is anticipated if a single prior art reference discloses all the claimed limitations arranged or combined in the same way as in the claim.” HTC Corp., 877 F.3d at 1368; see also 35 U.S.C. § 102. The prior art reference can dis- close each limitation of the claimed invention either ex- pressly or inherently. Eli Lilly & Co. v. Los Angeles Biomedical Rsch. Inst. At Harbor-UCLA Med. Ctr., 849 F.3d 1073, 1074 (Fed. Cir. 2017). Case: 22-2304 Document: 48 Page: 5 Filed: 07/23/2024

TENNANT CO. v. OXYGENATOR WATER TECHNOLOGIES, INC. 5

The Board found that both Wikey and Davies “appear[] to disclose each limitation of claim 13 except ‘microbubbles and nanobubbles having a bubble diameter of less than 50 microns.’” J.A. 22, 40–41. Although there seems to have been no issue as to whether Wikey and Davies disclose mi- crobubbles, the Board noted that neither Wikey nor Davies disclosed nanobubbles, which is a requirement of claim 13 of the ’415 patent. The issue is therefore whether Wikey or Davies discloses the nanobubble limitation. Tennant makes four distinct arguments in support of its position. Tennant first contends that its testing of the devices from Wikey and Davies demonstrates anticipation. Ten- nant’s expert re-created the device disclosed in Wikey and tested to see if it produced microbubbles and nanobubbles. “Microbubble” is defined as “a bubble with a diameter less than 50 microns.” ’415 patent, col. 4, ll. 10–11. “Nanobub- ble” is “a bubble with a diameter less than that necessary to break the surface tension of water,” ’415 patent, col. 4, ll. 12–13, which Tennant’s expert testified was “[r]oughly 100 nanometers” (0.1 microns), J.A. 6048. The expert used an imaging tool which showed that the Wikey device cre- ated microbubbles.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pegram v. Herdrich
530 U.S. 211 (Supreme Court, 2000)
New Hampshire v. Maine
532 U.S. 742 (Supreme Court, 2001)
Tyler Refrigeration v. Kysor Industrial Corporation
777 F.2d 687 (Federal Circuit, 1985)
In Re William J. King
801 F.2d 1324 (Federal Circuit, 1986)
In Re Ackenbach
45 F.2d 437 (Customs and Patent Appeals, 1930)
HTC Corp. v. Cellular Communications Equipment, LLC
877 F.3d 1361 (Federal Circuit, 2017)
In re Nomiya
509 F.2d 566 (Customs and Patent Appeals, 1975)

Cite This Page — Counsel Stack

Bluebook (online)
Tennant Co. v. Oxygenator Water Technologies, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/tennant-co-v-oxygenator-water-technologies-inc-cafc-2024.